Upgrade to SI Premium - Free Trial

Celularity (CELU)

0.73 -0.07 (8.75%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/3/25 *Est.)

Latest Headlines

Form 8-K Celularity Inc For: Jun 26 June 30, 2026 9:01 AM - SEC Filing Form 8-K Celularity Inc For: Jun 19 June 25, 2026 5:27 PM - SEC Filing Form 4 Celularity Inc For: Jun 19 Filed by: Philip & Daniele Barach Family Trust June 23, 2026 10:14 AM - SEC Filing Form 4 Celularity Inc For: Jun 19 Filed by: Barach Philip Alan June 23, 2026 10:14 AM - SEC Filing Form 4 Celularity Inc For: Jun 19 Filed by: Barach Daniele Wolf June 23, 2026 10:13 AM - SEC Filing Form SCHEDULE 13D/A Celularity Inc Filed by: Philip & Daniele Barach Family Trust June 23, 2026 6:04 AM - SEC Filing Form 8-K Celularity Inc For: Jun 09 June 12, 2026 5:16 PM - SEC Filing Celularity makes cell therapy available in Florida under new state law June 4, 2026 8:03 AM - StreetInsider Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies June 4, 2026 8:00 AM - StreetInsider Form 8-K Celularity Inc For: May 29 June 3, 2026 5:22 PM - SEC Filing Celularity names Rick Gonzalez as chief commercial officer June 3, 2026 4:15 PM - StreetInsider Celularity Releases CEO Letter to Shareholders June 3, 2026 4:15 PM - StreetInsider Celularity names Rick Gonzalez as chief commercial officer June 3, 2026 8:00 AM - StreetInsider Celularity Appoints Rick Gonzalez as Chief Commercial Officer June 3, 2026 8:00 AM - StreetInsider Celularity Receives Nasdaq Notice Regarding Form 10-Q May 29, 2026 5:15 PM - StreetInsider Form 8-K Celularity Inc For: May 21 May 28, 2026 5:48 PM - SEC Filing Form NT 10-Q Celularity Inc For: Mar 31 May 15, 2026 4:38 PM - SEC Filing Celularity regains NASDAQ compliance after filing delayed annual report May 1, 2026 4:33 PM - StreetInsider Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation May 1, 2026 4:30 PM - StreetInsider Form 10-K Celularity Inc For: Dec 31 April 30, 2026 4:10 PM - SEC Filing NEXGEL names Ian Blackman as chief financial officer April 27, 2026 9:00 AM - StreetInsider NEXGEL Appoints Ian Blackman as Chief Financial Officer April 27, 2026 9:00 AM - Globe NewsWire Form 3 Celularity Inc For: Apr 20 Filed by: Barach Philip Alan April 24, 2026 6:41 PM - SEC Filing Form 3 Celularity Inc For: Apr 20 Filed by: Barach Daniele Wolf April 24, 2026 6:41 PM - SEC Filing Form 3 Celularity Inc For: Apr 20 Filed by: Philip & Daniele Barach Family Trust April 24, 2026 6:40 PM - SEC Filing Form SCHEDULE 13D/A Celularity Inc Filed by: Philip & Daniele Barach Family Trust April 22, 2026 10:17 AM - SEC Filing Celularity amends deal terms with NexGel, sets $13.3 million consideration April 21, 2026 9:08 AM - StreetInsider Form 8-K Celularity Inc For: Apr 09 April 21, 2026 9:06 AM - SEC Filing NEXGEL completes Celularity acquisition with $5.5 million financing April 21, 2026 9:00 AM - StreetInsider NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment April 21, 2026 9:00 AM - StreetInsider Celularity Announces Closing of Transaction with NexGel April 21, 2026 8:30 AM - StreetInsider Celularity receives NASDAQ notice for late annual report filing April 17, 2026 4:35 PM - StreetInsider Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing April 17, 2026 4:35 PM - StreetInsider Form 4 Celularity Inc For: Apr 13 Filed by: Brigido Stephen April 15, 2026 4:31 PM - SEC Filing Form 4 Celularity Inc For: Apr 13 Filed by: Hariri Robert J April 15, 2026 4:31 PM - SEC Filing Form 4 Celularity Inc For: Apr 13 Filed by: Haines John R April 15, 2026 4:31 PM - SEC Filing Full Article List